|                      Clinical Data Interchange Standards Consortium                - Goals, Mission, Accomplishments                   Rebecca Daniels                  Kusha and Udo Siegmannb         Clinical Data                  Interchange Standards Consortiuma, Austin (Texas, USA), and PAREXELb,                  Berlin (Germany)                   
                 The Clinical Data Interchange Standards Consortium (CDISC) is developing                industry-wide standards to facilitate the acquisition, exchange,                submission and archive of electronic clinical data for the biopharmaceutical                product development industry. Long-term desired outcomes of CDISC                are:                                                           •                  A holistic approach to standards, facilitating data interchange                   from sites through regulatory submission, utilizing XML;                                        •                  Standards for data acquisition supporting the population of                   cross-trial warehouses and standard review tools;                                       • HL7- (Health Level 7) CDISC models harmonized to yield value                  for both clinical research and healthcare, thus supporting the                  electronic sharing of information between health records and                  clinical trials;          •    Global adoption of CDISC data standards.                        Four CDISC standards are now available: Operational Data Model                    (ODM) Version 1.2; Laboratory Data Standards (LAB) Version                    1.0.1; Submission Data Standard (SDS) Version 3; and a set                    of Analysis Dataset Models. The first two are focused on data                    acquisition and the last two on data submission and review.                    The primary activities of the CDISC volunteer modeling                    teams, at this point, are directed towards stabilizing and                    ensuring interoperability among these CDISC standards, themselves,                    and with the healthcare data standard (Reference Information                    Model) developed through HL7.                     CDISC has a formal relationship with HL7 and collaborates directly                    with HL7 and FDA and other interested groups through the Regulated                    Clinical Research Information Management (RCRIM) Technical                    Committee. There are additional standards being developed and                    accredited through the RCRIM, including Submission Data Standards                    for                                           •                  animal data,                   •                   product stability data,                   •                   clinical trial protocol                  representation standards,   • ECG waveform standards.                      A key opportunity recognized for CDISC and HL7 is to be able                    to develop common informatics platforms for the improved                    sharing of clinical research data and healthcare data. Such                    standards would improve processes for all involved with clinical                    research - clinicians and investigators, biopharmaceutical                    industry stakeholders and regulatory reviewers.                                                            Key words Clinical Data Interchange                    Standards Consortium • Clinical data management                                  |